Your browser doesn't support javascript.
loading
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.
John, Liza B; Devaud, Christel; Duong, Connie P M; Yong, Carmen S; Beavis, Paul A; Haynes, Nicole M; Chow, Melvyn T; Smyth, Mark J; Kershaw, Michael H; Darcy, Phillip K.
Afiliação
  • John LB; Authors' Affiliations: Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria; Department of Pathology, University of Melbourne; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville; Department of Immunology, Monash University, Clayton; Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research; and School of Medicine, University of Queensland, Herston, Queensland, Australia.
Clin Cancer Res ; 19(20): 5636-46, 2013 Oct 15.
Article em En | MEDLINE | ID: mdl-23873688
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Subpopulações de Linfócitos T / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Subpopulações de Linfócitos T / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article